title: Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.
abstract: Acute intermittent porphyria (AIP) is an autosomal-dominant condition resulting from a partial deficiency of the ubiquitously expressed enzyme porphobilinogen deaminase. Although its clinical expression is highly variable, a minority of patients suffer recurrent life-threatening neurovisceral attacks despite optimal medical therapy. Because the liver is the major source of excess precursor production, liver transplantation (LT) represents a potentially effective treatment for severely affected patients. Using data from the U.K. Transplant Registry, we analyzed all transplants performed for AIP in the United Kingdom and Ireland. Between 2002 and 2010, 10 patients underwent LT for AIP. In all cases, the indication for transplantation was recurrent, biochemically proven, medically nonresponsive acute attacks of porphyria resulting in significantly impaired quality of life. Five patients had developed significant neurological morbidities such as paraplegia before transplantation. The median follow-up time was 23.4 months, and there were 2 deaths from multiorgan failure at 98 days and 26 months. Eight recipients were alive for 3.2 to 109 months after transplantation. Complete biochemical and symptomatic resolution was observed in all patients after transplantation. However, there was a high rate of hepatic artery thrombosis (HAT; 4/10), with 1 patient requiring regrafting. The effects of previous neuronal damage such as joint contractures were not improved by transplantation. Thus, impaired quality of life in the surviving patients was usually a result of preoperative complications. Refractory AIP is an excellent indication for LT, and long-term outcomes for carefully selected patients are good. There is, however, an increased incidence of HAT in these patients, and we recommend routine antiplatelet therapy after transplantation.
authors: Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. j.k.dowman@bham.ac.uk
authors: Joanna K
authors: JK
authors: Dowman
authors: Bridget K
authors: BK
authors: Gunson
authors: Darius F
authors: DF
authors: Mirza
authors: Simon R
authors: SR
authors: Bramhall
authors: Mike N
authors: MN
authors: Badminton
authors: Philip N
authors: PN
authors: Newsome
references: N Engl J Med. 1998 Jun 18;338(25):1853-4
references: 9634374
references: Transplant Proc. 2010 Oct;42(8):2970-2
references: 20970585
references: J Intern Med. 1996 Oct;240(4):195-201
references: 8918510
references: Semin Liver Dis. 1998;18(1):43-52
references: 9516677
references: Am J Epidemiol. 1999 Jun 1;149(11):1010-5
references: 10355376
references: Transplantation. 2007 Sep 15;84(5):572-9
references: 17876268
references: Liver Transpl. 2006 Jan;12(1):146-51
references: 16382467
references: Clin Nephrol. 2008 May;69(5):339-46
references: 18538096
references: J Am Coll Surg. 2009 May;208(5):896-903; discussion 903-5
references: 19476857
references: J Clin Pathol. 1968 Jul;21(4):501-7
references: 5697352
references: Lancet. 2004 Feb 28;363(9410):705-6
references: 15001330
references: J Intern Med. 2000 Oct;248(4):319-25
references: 11086643
references: Transpl Int. 2010 Jun;23(6):e18-21
references: 20028496
references: Clin Chem. 2009 Jul;55(7):1406-14
references: 19460837
references: Ann Intern Med. 2005 Mar 15;142(6):439-50
references: 15767622
references: Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):93-6
references: 20133237
references: Liver Transpl. 2007 Sep;13(9):1219-27
references: 17763398
references: Lancet. 2010 Mar 13;375(9718):924-37
references: 20226990
references: J Intern Med. 2011 May;269(5):538-45
references: 21198994